162 related articles for article (PubMed ID: 15655715)
1. Extrapancreatic effects of GIP and GLP-1.
Vella A; Rizza RA
Horm Metab Res; 2004; 36(11-12):830-6. PubMed ID: 15655715
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Type 2 Diabetes and Obesity on the Basis of the Incretin System: The 2021 Banting Medal for Scientific Achievement Award Lecture.
Holst JJ
Diabetes; 2021 Nov; 70(11):2468-2475. PubMed ID: 34711671
[TBL] [Abstract][Full Text] [Related]
3. Glucose effectiveness: Lessons from studies on insulin-independent glucose clearance in mice.
Ahrén B; Pacini G
J Diabetes Investig; 2021 May; 12(5):675-685. PubMed ID: 33098240
[TBL] [Abstract][Full Text] [Related]
4. Relationships between gastric emptying, postprandial glycemia, and incretin hormones.
Marathe CS; Rayner CK; Jones KL; Horowitz M
Diabetes Care; 2013 May; 36(5):1396-405. PubMed ID: 23613599
[No Abstract] [Full Text] [Related]
5. The impact of GLP-1 signalling on the energy metabolism of pancreatic islet β-cells and extrapancreatic tissues.
Peart LA; Draper M; Tarasov AI
Peptides; 2024 May; ():171243. PubMed ID: 38788902
[TBL] [Abstract][Full Text] [Related]
6. New physiological effects of the incretin hormones GLP-1 and GIP.
Asmar M
Dan Med Bull; 2011 Feb; 58(2):B4248. PubMed ID: 21299928
[TBL] [Abstract][Full Text] [Related]
7. Blueberry Supplementation Influences the Gut Microbiota, Inflammation, and Insulin Resistance in High-Fat-Diet-Fed Rats.
Lee S; Keirsey KI; Kirkland R; Grunewald ZI; Fischer JG; de La Serre CB
J Nutr; 2018 Feb; 148(2):209-219. PubMed ID: 29490092
[TBL] [Abstract][Full Text] [Related]
8. Alterations of glucose-dependent insulinotropic polypeptide and expression of genes involved in mammary gland and adipose tissue lipid metabolism during pregnancy and lactation.
Moffett RC; Irwin N; Francis JM; Flatt PR
PLoS One; 2013; 8(11):e78560. PubMed ID: 24236022
[TBL] [Abstract][Full Text] [Related]
9. Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass.
Shah M; Law JH; Micheletto F; Sathananthan M; Dalla Man C; Cobelli C; Rizza RA; Camilleri M; Zinsmeister AR; Vella A
Diabetes; 2014 Feb; 63(2):483-93. PubMed ID: 24089513
[TBL] [Abstract][Full Text] [Related]
10. Direct effects of exendin-(9,39) and GLP-1-(9,36)amide on insulin action, β-cell function, and glucose metabolism in nondiabetic subjects.
Sathananthan M; Farrugia LP; Miles JM; Piccinini F; Dalla Man C; Zinsmeister AR; Cobelli C; Rizza RA; Vella A
Diabetes; 2013 Aug; 62(8):2752-6. PubMed ID: 23545708
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain.
Gejl M; Lerche S; Egefjord L; Brock B; Møller N; Vang K; Rodell AB; Bibby BM; Holst JJ; Rungby J; Gjedde A
Front Neuroenergetics; 2013; 5():2. PubMed ID: 23543638
[TBL] [Abstract][Full Text] [Related]
12. Enteroendocrine secretion after Roux-en-Y gastric bypass: is it important?
Vella A
Neurogastroenterol Motil; 2013 Jan; 25(1):1-3. PubMed ID: 23279727
[TBL] [Abstract][Full Text] [Related]
13. The effect of a bile acid sequestrant on glucose metabolism in subjects with type 2 diabetes.
Smushkin G; Sathananthan M; Piccinini F; Dalla Man C; Law JH; Cobelli C; Zinsmeister AR; Rizza RA; Vella A
Diabetes; 2013 Apr; 62(4):1094-101. PubMed ID: 23250357
[TBL] [Abstract][Full Text] [Related]
14. The importance of the gut microbiota after bariatric surgery.
Aron-Wisnewsky J; Doré J; Clement K
Nat Rev Gastroenterol Hepatol; 2012 Oct; 9(10):590-8. PubMed ID: 22926153
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of DPP-4 inhibitors--new insights.
Vella A
J Clin Endocrinol Metab; 2012 Aug; 97(8):2626-8. PubMed ID: 22869847
[No Abstract] [Full Text] [Related]
16. Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: a pilot study.
Sathananthan A; Man CD; Micheletto F; Zinsmeister AR; Camilleri M; Giesler PD; Laugen JM; Toffolo G; Rizza RA; Cobelli C; Vella A
Diabetes Care; 2010 Sep; 33(9):2074-6. PubMed ID: 20805279
[TBL] [Abstract][Full Text] [Related]
17. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery.
Isbell JM; Tamboli RA; Hansen EN; Saliba J; Dunn JP; Phillips SE; Marks-Shulman PA; Abumrad NN
Diabetes Care; 2010 Jul; 33(7):1438-42. PubMed ID: 20368410
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics for type 2 diabetes: practical considerations for study design.
Vella A
J Diabetes Sci Technol; 2009 Jul; 3(4):705-9. PubMed ID: 20144317
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase-4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes.
Dalla Man C; Bock G; Giesler PD; Serra DB; Ligueros Saylan M; Foley JE; Camilleri M; Toffolo G; Cobelli C; Rizza RA; Vella A
Diabetes Care; 2009 Jan; 32(1):14-8. PubMed ID: 18931099
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model.
Samson SL; Gonzalez EV; Yechoor V; Bajaj M; Oka K; Chan L
Mol Ther; 2008 Nov; 16(11):1805-12. PubMed ID: 18781141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
